{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:14:11Z","timestamp":1762604051175},"reference-count":55,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea government","award":["2015R1A2A1A14001011"],"award-info":[{"award-number":["2015R1A2A1A14001011"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.04.084","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T14:00:45Z","timestamp":1494252045000},"page":"3333-3341","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses"],"prefix":"10.1016","volume":"35","author":[{"given":"Gayeon","family":"Won","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.04.084_b0005","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4269\/ajtmh.2000.62.644","article-title":"The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam","volume":"62","author":"Lin","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.04.084_b0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM 197 conjugate vaccine against typhoid fever in adults, children, and infants in south and Southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.084_b0015","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.04.084_b0020","first-page":"339","article-title":"Salmonella vaccines for use in humans: present and future perspectives","volume":"26","author":"Garmory","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2017.04.084_b0025","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/516128","article-title":"Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment","volume":"25","author":"Wain","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.084_b0030","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/JCM.36.6.1595-1600.1998","article-title":"Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India","volume":"36","author":"Shanahan","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0035","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1086\/518144","article-title":"The use of typhoid vaccines in Asia: the DOMI experience","volume":"45","author":"Ochiai","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.084_b0040","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.vaccine.2007.08.027","article-title":"Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"Fraser","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.084_b0045","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.084_b0050","first-page":"1","article-title":"Safety and Immunogenicity of Salmonella Typhi Vi conjugate vaccine (PedaTyph\u2122) in children upto five years","volume":"3","author":"Chinnasami","year":"2013","journal-title":"Int J Sci Res Publ IJSRP"},{"key":"10.1016\/j.vaccine.2017.04.084_b0055","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1016\/j.vaccine.2005.07.111","article-title":"Vaccines against typhoid fever","volume":"24","author":"Guzman","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.084_b0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0168-1656(95)00123-9","article-title":"Bacterial ghosts: non-living candidate vaccines","volume":"44","author":"Szostak","year":"1996","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-1656(00)00298-4","article-title":"Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells","volume":"83","author":"Haslberger","year":"2000","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/14760584.3.6.681","article-title":"Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors","volume":"3","author":"Walcher","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.04.084_b0075","first-page":"75","article-title":"Controlled field trial on the effectiveness of one and two doses of acetone-inactivated and dried typhoid vaccine","volume":"52","author":"Tapa","year":"1975","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.04.084_b0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0264-410X(96)00141-7","article-title":"Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines","volume":"15","author":"Mader","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.084_b0085","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1016\/j.vaccine.2014.09.014","article-title":"Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL\/6 mice","volume":"32","author":"Chen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.084_b0090","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0264-410X(98)00423-X","article-title":"New strategies for combination vaccines based on the extended recombinant bacterial ghost system","volume":"17","author":"Eko","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.084_b0095","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/hv.4.3.5393","article-title":"Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness","volume":"4","author":"Eko","year":"2008","journal-title":"Human Vaccines"},{"key":"10.1016\/j.vaccine.2017.04.084_b0100","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1128\/IAI.73.8.4810-4817.2005","article-title":"Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157: H7 bacterial ghosts protects mice against lethal challenge","volume":"73","author":"Mayr","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.04.084_b0105","unstructured":"Stevens M. Bacterial ghosts modulation of innate immunity: immune responses during chlamydia infection; 2015."},{"key":"10.1016\/j.vaccine.2017.04.084_b0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1517\/14712598.1.5.765","article-title":"Bacterial ghosts as carrier and targeting systems","volume":"1","author":"Lubitz","year":"2001","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2017.04.084_b0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-3659(99)00099-1","article-title":"Bacterial ghosts as drug carrier and targeting vehicles","volume":"61","author":"Huter","year":"1999","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.04.084_b0120","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/IAI.70.4.1739-1749.2002","article-title":"Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine","volume":"70","author":"Kang","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.04.084_b0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.vetmic.2014.01.004","article-title":"Tightly regulated bacteriolysis for production of empty Salmonella Enteritidis envelope","volume":"169","author":"Jawale","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0130","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1016\/j.vaccine.2014.03.090","article-title":"Chemically induced Salmonella enteritidis ghosts as a novel vaccine candidate against virulent challenge in a rat model","volume":"32","author":"Vinod","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.084_b0135","doi-asserted-by":"crossref","first-page":"e78193","DOI":"10.1371\/journal.pone.0078193","article-title":"Development of a biosafety enhanced and immunogenic Salmonella Enteritidis ghost using an antibiotic resistance gene free plasmid carrying a bacteriophage lysis system","volume":"8","author":"Jawale","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.04.084_b0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/01652176.2015.1029598","article-title":"Salmonella ghosts expressing enterotoxigenic Escherichia coli k88ab, k88ac, k99, and fasa fimbrial antigens induce robust immune responses in a mouse model","volume":"35","author":"Hur","year":"2015","journal-title":"Veter Quart"},{"key":"10.1016\/j.vaccine.2017.04.084_b0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/cyto.1998.0426","article-title":"Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR","volume":"11","author":"Overbergh","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2017.04.084_b0150","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/CVI.00289-13","article-title":"Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States","volume":"20","author":"Trebicka","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0160","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0092-8674(84)90050-3","article-title":"Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis","volume":"36","author":"Izant","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.04.084_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/545741","article-title":"Sponge-like: a new protocol for preparing bacterial ghosts","volume":"2013","author":"Amara","year":"2013","journal-title":"Sci World J"},{"key":"10.1016\/j.vaccine.2017.04.084_b0170","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1016\/S0021-9258(18)83778-4","article-title":"Evidence for membrane-bound oligomerization of bacteriophage phi X174 lysis protein-E","volume":"264","author":"Bl\u00e4si","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.04.084_b0175","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/CVI.00016-14","article-title":"Salmonella enterica serovar Enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses","volume":"21","author":"Jawale","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0180","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1128\/IAI.66.12.5630-5635.1998","article-title":"Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans","volume":"66","author":"Kantele","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.04.084_b0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00915547","article-title":"The common mucosal immune system and current strategies for induction of immune responses in external secretions","volume":"7","author":"Mestecky","year":"1987","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vetimm.2015.01.010","article-title":"A new enterotoxigenic Escherichia coli vaccine candidate constructed using a Salmonella ghost delivery system: comparative evaluation with a commercial vaccine for neonatal piglet colibacillosis","volume":"164","author":"Hur","year":"2015","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0195","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1128\/IAI.68.7.3830-3839.2000","article-title":"Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage","volume":"68","author":"Externest","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.04.084_b0200","series-title":"Tracking the dynamics of salmonella specific T cell responses. Visualizing immunity","first-page":"179","author":"Moon","year":"2009"},{"key":"10.1016\/j.vaccine.2017.04.084_b0205","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197010012831406","article-title":"Typhoid fever: pathogenesis and immunologic control","volume":"283","author":"Hornick","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.084_b0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.med.52.1.259","article-title":"Salmonella: a model for bacterial pathogenesis","volume":"52","author":"Ohl","year":"2001","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2017.04.084_b0215","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.8097338","article-title":"Development of TH1 CD4+ T cells through IL-12","volume":"260","author":"Hsieh","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.04.084_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2017.04.084_b0225","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.vaccine.2017.04.084_b0230","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.0902796","article-title":"IL-23 receptor regulates unconventional IL-17\u2013producing T cells that control bacterial infections","volume":"184","author":"Riol-Blanco","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0235","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.084_b0240","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/CVI.00115-14","article-title":"Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines","volume":"21","author":"Boyd","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0245","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.084_b0250","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/CVI.00245-09","article-title":"Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal","volume":"16","author":"Pulickal","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0168-3659(02)00267-5","article-title":"Bacterial ghosts as vaccine candidates for veterinary applications","volume":"85","author":"Jalava","year":"2002","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.04.084_b0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.micres.2015.03.011","article-title":"Efficient production of safety-enhanced Escherichia coli ghosts by tandem expression of PhiX 174 mutant gene E and staphylococcal nuclease A gene","volume":"176","author":"Zhu","year":"2015","journal-title":"Microbiol Res"},{"key":"10.1016\/j.vaccine.2017.04.084_b0265","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.fsi.2015.05.030","article-title":"A controllable bacterial lysis system to enhance biological safety of live attenuated Vibrio anguillarum vaccine","volume":"45","author":"Chu","year":"2015","journal-title":"Fish Shellfish Immunol"},{"key":"10.1016\/j.vaccine.2017.04.084_b0270","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/S0264-410X(03)00388-8","article-title":"Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits","volume":"21","author":"Eko","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.084_b0275","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4161\/bbug.1.5.12540","article-title":"The bacterial ghost platform system: production and applications","volume":"1","author":"Langemann","year":"2010","journal-title":"Bioeng Bugs"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T09:40:39Z","timestamp":1659001239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":55,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17305856"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}